Previous Article | Next Article 
Journal of Clinical Microbiology, May 1998, p. 1285-1289, Vol. 36, No. 5
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Identification and Analysis of a New
vacA Genotype Variant of Helicobacter pylori in
Different Patient Groups in Germany
Sonja
Strobel,1
Stefan
Bereswill,1,*
Peter
Balig,2
Peter
Allgaier,3
Hans-Günther
Sonntag,4 and
Manfred
Kist1
Institute of Medical Microbiology and
Hygiene1 and
Department of Internal
Medicine, University Hospital,3
University of Freiburg, D-79104 Freiburg, Kaiser-Joseph-Straße
186-188, D-79098 Freiburg,2 and
Institute of Hygiene, University of Heidelberg, D-69120
Heidelberg,4 Germany
Received 10 September 1997/Returned for modification 16 December
1997/Accepted 16 February 1998
 |
ABSTRACT |
The vacuolating cytotoxin of Helicobacter pylori (VacA)
is known to cause cell damage to mammalian cells and is suspected to
give rise to gastric epithelial lesions that might lead to peptic ulcer
disease. As shown recently, the gene encoding VacA exhibits genetic
variation, with three different families of signal sequences (s1a, s1b,
and s2) and two families of midregion sequences (m1 and m2). In order
to investigate the relationship between the presence of specific
vacA genotypes and peptic ulceration, the vacA
genotypes of 158 clinical isolates of H. pylori were determined. The study group consisted of 106 patients with duodenal ulceration; 52 patients with nonulcer dyspepsia (NUD) were used as
controls. H. pylori of genotype s1 was isolated from
96% of the patients with ulcerations, whereas genotype s2 was only
present in 4%, indicating a strong correlation between the
vacA genotype and peptic ulceration (P < 0.001). In contrast, 31% of the patients from the NUD control group
were infected with strains of vacA genotype s2. Particular
midregion genotypes (m1 and m2) were not associated with clinical
manifestations. The midregions from 18% of the isolates could not be
classified by the proposed scheme. DNA sequencing revealed high
homology between the untypeable midregions and that of genotype m1,
with multiple base pair exchanges, some affecting the primer annealing
site. Compared to those of m1 and m2 alleles, the divergent midregions
from untypeable strains showed clustering, indicating the presence of a
further subfamily of sequences in the midregion of vacA in
German isolates, for which we propose the term "m1a." A new
specific primer that we designed for typing m1a isolates might be
useful in other studies.
 |
INTRODUCTION |
Helicobacter pylori is a
gram-negative spiral bacterium that colonizes the gastric mucosa and is
able to persist over decades if the infection is not treated. The
chronic infection often occurs without symptoms, but some individuals
develop severe features of upper gastrointestinal diseases such as
peptic ulcer disease (PUD), gastric adenocarcinoma, and
mucosa-associated lymphoid tissue (MALT) lymphoma (1, 13).
The vacuolating cytotoxin is one of the putative virulence factors of
H. pylori that might lead to ulcerations. It induces
massive formation of acidic vacuoles in the cytoplasm of gastric
epithelial cells in vivo (14) as well as in vitro in primary
epithelial cells (9) or in permanent cell lines. It has also
been demonstrated that oral administration of purified VacA to mice
causes injury of the gastric mucosa (14). The gene coding
for the cytotoxin exhibits a mosaic of different alleles, which can be
separately detected by PCR (2, 3, 6). For the N-terminal
region of vacA, coding for the signal peptide, three
different families of sequences, termed s1a, s1b, and s2, can be
differentiated. The midregion of vacA is represented by two
different families of alleles, termed m1 and m2 (2).
The aim of this study was (i) to perform vacA typing of
H. pylori isolated from German patients in order to
test the applicability of this method to isolates from a population not
yet examined, (ii) to evaluate the association of vacA
genotypes with peptic ulceration and nonulcer dyspepsia (NUD), and
(iii) to assess the association of vacA genotypes with the
presence of the pathogenicity marker cagA.
 |
MATERIALS AND METHODS |
Patients.
Independent clinical isolates of H. pylori were obtained from 158 adults who underwent
gastroduodenoscopy. Of these, 106 patients (mean age, 51 years)
presenting with duodenal ulcerations (PUD) with a minimum ulcer size of
5 mm have been enrolled in a multicenter study (7) including
28 centers all over Germany. Biopsies of a control group consisting of
52 patients (mean age, 47 years) with NUD were taken by two
gastroenterologists. Strains from patients with gastric ulceration,
gastric cancer, or MALT lymphoma or who had taken antimicrobial agents
4 weeks prior to endoscopy were not included in the study.
Isolation and culture conditions.
During endoscopy one
antrum and one corpus mucosal biopsy were obtained from each patient.
Each biopsy specimen was placed in a transport medium (Portagerm
Pylori; Biomerieux) and sent to the laboratory within 24 h. The
specimens were ground with a pellet pestle, spread on solid-agar
plates, and incubated under microaerobic conditions at 37°C for 2 to
5 days. Yeast extract-cysteine blood agar base (Difco), supplemented
with 0.0005% hemin, 0.007% potassium hydroxide, 0.001% vitamin K,
10% horse serum, 10% washed human erythrocytes, vancomycin (10 mg/liter), trimethoprim (5 mg/liter), and nystatin (1 mg/liter) after
autoclaving, was used as the growth medium. Bacteria were identified as
H. pylori by standard criteria (12). The
primary cultures grown from antrum and corpus biopsy specimens were
transferred to Microbank cryovials (Mast Diagnostica) and stored frozen
at
70°C. These are referred to as stock cultures.
PCR-based typing.
The DNA sequences of the primer
oligonucleotides used for PCR and sequencing and the sizes of the
corresponding PCR products are listed in Table
1. For PCR analysis, bacteria from frozen stock cultures were grown for 48 h in brucella broth supplemented with 10% fetal calf serum at 37°C with shaking under microaerobic conditions. The cells were harvested by centrifugation and resuspended in distilled water. A 1-µl aliquot from a 100-fold dilution of this
suspension was analyzed in a PCR mixture (50 ml) containing 1 U of
Taq DNA polymerase and 25 pmol of each primer in a buffer system described previously (4). Amplification was done in 30 cycles consisting of 94, 50, and 72°C (for 1 minute each). The PCR
products were electrophoretically separated on a 2.5% agarose gel and
stained with ethidium bromide.
DNA sequence analysis of the vacA midregion.
To
determine the nucleotide sequence of the vacA midregion, a
785-bp fragment was amplified by using the two primers VA6-F and VA5-R,
which bind to conserved regions flanking the midregion of the
vacA gene (Table 1). The PCR products were purified by using
the QIAquik PCR purification kit from Qiagen and sequenced with the
PRISM ready reaction dye cycle sequencing kit (Applied Biosystems),
including fluorescence-labeled dideoxynucleotides. The fluorescent
reaction products were separated on a denaturing polyacrylamide gel and
analyzed with an Applied Biosystems 373A automated DNA-sequencing
machine. The DNA sequence was analyzed with the HUSAR software package
provided by the German Cancer Research Center in Heidelberg. The
detailed alignments were done with GAP, CLUSTAL, or BESTFIT software.
The dendrogram was constructed with pc/gene software, version 6.8, from
IntelliGenetics Inc.
Detection of cagA.
The presence of the cagA
gene was ascertained by PCR with primer oligonucleotides CAG-L and
CAG-R (Table 1) under the cycling conditions described above.
Nucleotide sequence accession numbers.
The vacA
midregion of strains 003, 013, 026, 031, and 049 have been assigned
EMBL database accession no. Y14740, Y14741, Y14742, Y14743, and Y14744,
respectively.
 |
RESULTS |
Distribution of vacA alleles in patient groups.
A
total of 158 strains were investigated to determine their
vacA genotypes. Of these, 106 were isolated from patients
who suffered from duodenal ulceration (PUD) and 52 were isolated from patients with NUD. All three alleles of the vacA signal
sequence could be detected and typed in all isolates as either s1a,
s1b, or s2. Allele s1a was found in the PUD group with higher frequency (90%) than in the NUD group (58%). The allele s2, known to be associated with less-cytotoxic activity and with the absence of the
pathogenicity-related gene cagA, was found in the NUD group at a much higher frequency (31%) than in the PUD group (4%). Both associations revealed statistical significance (P < 0.001 by the
2 test). The midregion subtypes earlier
defined as m1 and m2 (2, 3) were detectable in only 81.5%
of the isolates, whereas in 18.5% no PCR product was obtained by using
the primers specific for m1 and m2. The midregion subtype present in
these strains was given the preliminary designation mx, which could be
identified as a distinct subtype of m1 by further criteria (see below).
With respect to this classification, the m1 and m2 alleles were equally distributed over the PUD and NUD groups. The data are summarized in
Table 2.
Different vacA genotypes in strains from one
patient.
For each patient, the isolate from the gastric antrum and
the isolate from the gastric corpus were analyzed separately. We had
only one case in which H. pylori isolates with more
than one vacA allele were obtained from a single patient.
Strains 091A (isolated from the antrum) and 091C (isolated from the
corpus) showed genotypes s1a m2 and s2 m2, respectively. This implied that the patient was infected with more than one strain. The results from this patient were not included in Table 2.
Further characterization of the midregion subtype mx.
The 29 strains which gave no PCR product with the primers for typing m1 or m2
alleles were further investigated by DNA sequence analysis and by PCR
with specifically designed primer oligonucleotides. For this purpose,
the DNA sequences of 785-bp fragments including the divergent
vacA midregions from five independent randomly selected untypeable isolates were determined. The analysis revealed six single-base-pair transitions within the binding site for the m1 antisense primer, VA3-R, whereas the binding site m1 sense primer, VA3-F, was completely conserved (Table
3). Binding sites for primers specific
for the m2 allele were absent. In each of the five clinical isolates,
which originated from patients living in different areas of Germany,
the nucleotide exchanges were identical, with the exception that in
isolate 026 an additional C-to-T transition was present (Table 3). In
order to further investigate whether this variation was responsible for
the insufficient amplification and to classify further mx strains, two
new primers, VA3.1-R and VA3.2-R, were designed. The nucleotide
sequence of primer VA3.1-R was identical with that of the altered
binding site found in mx strains, and the primer VA3.2-R carried the
sequence 5 bp upstream from the original annealing site (Tables 1 and
3). To determine whether these primers were suitable for investigation
of the mx subtype, individual m1, m2, and mx strains were analyzed by
PCR with primers VA3.1-R and VA3.2-R in combination with primer VA3-F (Fig. 1). This analysis revealed that
primer VA3.1-R gave a strong amplification product with mx strains
whereas primer VA3.2-R gave only weak amplification of the mx midregion
sequence. Neither primer amplified the midregions of m1 or m2 strains,
indicating that primer VA3.1-R, especially, could be useful to
specifically detect the mx subtype. This was further confirmed by
analysis of all 29 mx strains which could be successfully classified by this method (data not shown).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 1.
PCR analysis of the vacA midregion of defined
m1, m2, and mx strains. Isolates 005C (m1), 004C (m2), 003C (mx), and
013C (mx) were analyzed with the four primer combinations which
specifically detect the vacA subtypes m1 (VA3-F and -R)
(lanes 1), m2 (VA4-F and -R) (lanes 2), and mx (VA3.1-R and VA3-F and
VA3.2-R and VA3-F) (lanes 3 and 4, respectively). PCR products were
separated on a 2.5% agarose gel and stained with ethidium bromide. The
size of defined marker DNA fragments (1-kb DNA ladder; BRL) is
indicated in base pairs to the right.
|
|
To further assess the homology among the mx, m1, and m2 alleles on the
basis of the DNA sequence, the 785-bp fragments from five strains were
aligned with the corresponding vacA sequences from
databases. This analysis revealed that the mx region exhibits a
significantly closer homology with m1 strains (88%) than with m2
strains (74%). The fact that the homology was significantly higher
within mx strains (95 to 98%) indicated that the mx group represents a
cluster resembling a new subtype of m1, which could be present only in
European isolates (Table 4 and Fig.
2). In this context it is interesting to
note that the vacA sequence published earlier by Schmitt and
Haas (15) is also of the mx type.
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Nucleotide sequence identity observed in alignments of
785-bp fragments from the vacA divergent midregions and
homologous regions in EMBL database sequences
|
|

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 2.
Dendrogram showing the relationships among
vacA midregion sequences of subtypes m1, m2, and m1a. The
midregion sequences from 11 German H. pylori isolates
were aligned. The DNA regions analyzed correspond to nucleotides 2629 to 3078 in the vacA gene HP05676 deposited in the GenBank
and EMBL databases, which served as a reference (6).
|
|
Relationship between vacA genotype and CagA
status.
The presence of the pathogenicity marker gene
cagA was highly correlated with the vacA signal
sequence type s1a (P < 0.001 by the
2
test). This link between cagA and allele s1a was not
exclusive, as indicated by the detection of six
cagA-negative isolates exhibiting the vacA
genotype s1a and, conversely, three cagA-positive isolates exhibiting the vacA genotype s2.
 |
DISCUSSION |
The present study revealed that the vacA allele s1a of
H. pylori is strongly associated with PUD. On the other
hand, the vacA allele s2 was predominantly found in isolates
from patients with NUD and was very rare in strains isolated from ulcer
patients. Therefore, the vacA allele s2 is not suspected to
contribute to PUD.
It was reported in previous studies (2, 3, 6) that the
observed cytotoxic activity was higher in s1a m1 than in s1a m2 strains
and that cytotoxicity seemed to be completely absent in s2 m2 strains.
It was proposed, as the most likely explanation for the high prevalence
of the s1a genotype in the ulcer group, that the elevated toxicity of
s1a m1 strains might contribute to the development of ulcerations.
However, this explanation is not consistent with the findings of the
present study, which indicate that, in contrast to the genotype of the
signal sequence, the genotype of the midregion showed no correlation
with the outcome of disease. If it is true that the ulcerative effect
is exclusively dependent on cytotoxic activity, one would expect a
higher frequency of m1 genotypes in the ulcer group and correspondingly
more m2 genotypes in the NUD group. One explanation for these
contradictory observations could be that the toxin assay with HeLa
cells might not accurately reflect the in vivo effect occurring in the
duodenal epithelial cells. It is supposed that the cytotoxin enters the cell by receptor-mediated endocytosis (8), and if this is
true, the presence of specific receptor molecules on the surface of the
target cell should influence the efficacy of the cytotoxin. Another
explanation might be that factors other than VacA influence the
development of ulcers. As shown before, and also demonstrated in this
study, the vacA genotype s1a is strongly associated with the
presence of the pathogenicity marker cagA (2, 3),
whereas strains with vacA genotype s2 mostly lacked the
cagA gene. This may imply that vacA genotype s1a
is a marker for elevated virulence. Interestingly, the vacA
midregion allele m2 was correlated with a negative cagA
status (P < 0.001 by the
2 test) (Table
5).
It was one of the objectives of this study to evaluate whether the
vacA genotype might be a predictor of the duodenal ulcer risk of an infected person. However, our conclusions are limited by the
fact that the NUD control group, in contrast to the PUD group, was
heterogeneous and included patients with erosive gastritis as well as
persons who might have suffered from ulcers before or might suffer from
ulcers in the future. This potential selection bias could in part
explain the relatively high prevalence of genotype s1a in the NUD
group.
Nearly one-fifth of the H. pylori strains which were
isolated harbored a vacA genotype that could not be
classified by the proposed scheme (2, 3) and which we gave
the preliminary name mx. The genotypes of all 29 of these isolates have
been confirmed by allele-specific PCR, and 5 were additionally analyzed
by DNA sequencing. Because the mx type investigated in this study
highly resembled the midregion type m1, we would propose the term
"m1a," analogous to the terms s1a and -b used for the signal
sequence subtypes (2, 3). The results of the present study
also provided evidence that all m1a isolates are of clonal origin and
represent a distinct midregion genotype. To see such clear-cut
differences from the results of vacA typing of strains of
North American origin was surprising (2). To date, there is
one other published study about H. pylori isolates from
Japan, which reported that 84 of 87 clinical isolates were untypeable
with respect to the midregion of the vacA gene
(11). It would be of interest to evaluate in further studies
if the m1a genotype is restricted exclusively to Western Europe or if
it is also found in other geographic regions. We presume that
geographical clustering of vacA genotypes in different populations exists. The primer we designed for detecting genotype m1a
might be a useful tool in such studies.
 |
ACKNOWLEDGMENTS |
We thank Antonello Covacci for providing primers for detection of
cagA. We are grateful to Henriette Ries and Stefanie Pietsch for excellent technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute of
Medical Microbiology and Hygiene, Department of Medical Microbiology
and Hygiene, University of Freiburg, Hermann-Herder-Straße 11, D-79104 Freiburg, Germany. Phone: 49 761 203 6539. Fax: 49 761 203 6562. E-mail: bereswil{at}sun1.ukl.uni-freiburg.de.
 |
REFERENCES |
| 1.
|
Asaka, M.,
T. Kimura,
M. Kato,
M. Kudo,
K. Miki,
K. Ogoshi,
T. Kato,
M. Tatsuga, and D. D. Y. Graham.
1994.
Possible role of Helicobacter infection in early gastric cancer development.
Cancer
73:2691-2694[Medline].
|
| 2.
|
Atherton, J. C.,
P. Cao,
R. M. Peek,
M. K. R. Tummuru,
M. J. Blaser, and T. L. Cover.
1995.
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori.
J. Biol. Chem.
270:17771-17777[Abstract/Free Full Text].
|
| 3.
|
Atherton, J. C.,
M. R. Peek,
K. T. Tham,
T. L. Cover, and M. J. Blaser.
1997.
Clinical and pathological importance of heterogeneity in vacA, the cytotoxin gene of Helicobacter pylori.
Gastroenterology
112:92-95[Medline].
|
| 4.
|
Bereswill, S.,
A. Pahl,
P. Bellemann,
W. Zeller, and K. Geider.
1992.
Sensitive and species-specific detection of Erwinia amylovora by polymerase chain reaction analysis.
Appl. Environ. Microbiol.
58:3522-3526[Abstract/Free Full Text].
|
| 5.
|
Covacci, A.,
S. Censini,
M. Bugnoli,
R. Petracca,
D. Burroni,
G. Macchia,
A. Massone,
E. Papini,
Z. Xiang,
N. Figura, and R. Rappuoli.
1993.
Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.
Proc. Natl. Acad. Sci. USA
50:5791-5795.
|
| 6.
|
Cover, T. L.,
M. K. R. Tummuru,
P. Cao,
S. A. Thompson, and M. J. Blaser.
1994.
Divergence of genetic sequences for vacuolating cytotoxin among Helicobacter pylori strains.
J. Biol. Chem.
269:10566-10573[Abstract/Free Full Text].
|
| 7.
| Dammann, H. G., U. R. Fölsch,
E. G. Hahn, D. H. von Kleist, H. U. Klör, T. Kirchner, and M. Kist. 1997. Seven vs 14 day
treatment with pantoprazole, clarithromycin and metronidazole for cure
of H. pylori infection in duodenal ulcer patients. Gut
41(Suppl. 1):95.
|
| 8.
|
Garner, J. A., and T. L. Cover.
1996.
Binding and internalization of the Helicobacter pylori vacuolating cytotoxin by epithelial cells.
Infect. Immun.
64:4197-4203[Abstract].
|
| 9.
|
Harris, P. R.,
T. L. Cover,
D. R. Crowe,
J. M. Orenstein,
M. F. Graham,
M. J. Blaser, and P. D. Smith.
1996.
Helicobacter pylori cytotoxin induces vacuolation of primary human mucosal epithelial cells.
Infect. Immun.
64:4867-4871[Abstract].
|
| 10.
|
Hazell, S. L.,
R. H. Andrews,
H. M. Mitchell, and G. Daskalopoulous.
1997.
Genetic relationship among isolates of Helicobacter pylori: evidence for the existence of a Helicobacter pylori species-complex.
FEMS Microbiol. Lett.
150:27-32[Medline].
|
| 11.
|
Ito, Y.,
T. Azuma,
S. Ito,
H. Miyaji,
M. Hirai,
Y. Yamazaki,
F. Sato,
T. Kato,
Y. Kohli, and M. Kuriyama.
1997.
Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan.
J. Clin. Microbiol.
35:1710-1714[Abstract].
|
| 12.
|
Kist, M.
1991.
Diagnostische Verfahrensrichtlinien der DGHM: Isolierung und Identifizierung von Bakterien der Gattungen Campylobacter und Helicobacter.
Zentralbl. Bakteriol.
276:124-139[Medline].
|
| 13.
|
McColl, K. E.
1997.
Helicobacter pylori: clinical aspects.
J. Infect.
34:7-13[Medline].
|
| 14.
|
Phadnis, S. H.,
D. Ilver,
L. Janzon,
S. Normark, and T. U. Westblom.
1994.
Pathological significance and molecular characterization of the vacuolating cytotoxin gene of Helicobacter pylori.
Infect. Immun.
62:1557-1565[Abstract/Free Full Text].
|
| 15.
|
Schmitt, W., and R. Haas.
1994.
Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with IgA protease type exported protein.
Mol. Microbiol.
12:307-319[Medline].
|
| 16.
|
Telford, J. L.,
P. Ghiara,
M. Dell'Ocro,
M. Comanducci,
D. Burroni,
M. Bugnoli,
M. F. Tecce,
S. Censini,
A. Covacci,
Z. Xiang,
E. Papini,
C. Montecucco,
L. Parente, and R. Rappuoli.
1994.
Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.
J. Exp. Med.
179:1653-1658[Abstract/Free Full Text].
|
| 17.
|
Tummuru, M. K. R.,
T. L. Cover, and M. J. Blaser.
1994.
Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori.
Infect. Immun.
62:2609-2613[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, May 1998, p. 1285-1289, Vol. 36, No. 5
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Moder, K.-A., Layer, F., Konig, W., Konig, B.
(2007). Rapid screening of clarithromycin resistance in Helicobacter pylori by pyrosequencing. J Med Microbiol
56: 1370-1376
[Abstract]
[Full Text]
-
Glocker, E., Bogdan, C., Kist, M.
(2007). Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany. J Antimicrob Chemother
59: 874-879
[Abstract]
[Full Text]
-
Ghose, C., Perez-Perez, G. I., Torres, V. J., Crosatti, M., Nomura, A., Peek, R. M. Jr., Cover, T. L., Francois, F., Blaser, M. J.
(2007). Serological Assays for Identification of Human Gastric Colonization by Helicobacter pylori Strains Expressing VacA m1 or m2. CVI
14: 442-450
[Abstract]
[Full Text]
-
Glocker, E., Berning, M., Gerrits, M. M., Kusters, J. G., Kist, M.
(2005). Real-Time PCR Screening for 16S rRNA Mutations Associated with Resistance to Tetracycline in Helicobacter pylori. Antimicrob. Agents Chemother.
49: 3166-3170
[Abstract]
[Full Text]
-
Saribasak, H., Salih, B. A., Yamaoka, Y., Sander, E.
(2004). Analysis of Helicobacter pylori Genotypes and Correlation with Clinical Outcome in Turkey. J. Clin. Microbiol.
42: 1648-1651
[Abstract]
[Full Text]
-
Carroll, I. M., Ahmed, N., Beesley, S. M., Khan, A. A., Ghousunnissa, S., Morain, C. A. O, Smyth, C. J.
(2003). Fine-Structure Molecular Typing of Irish Helicobacter pylori Isolates and Their Genetic Relatedness to Strains from Four Different Continents. J. Clin. Microbiol.
41: 5755-5759
[Abstract]
[Full Text]
-
Letley, D. P., Rhead, J. L., Twells, R. J., Dove, B., Atherton, J. C.
(2003). Determinants of Non-toxicity in the Gastric Pathogen Helicobacter pylori. J. Biol. Chem.
278: 26734-26741
[Abstract]
[Full Text]
-
Lim, C.-Y., Lee, K.-H., Cho, M.-J., Chang, M.-W., Kim, S.-Y., Myong, N.-H., Lee, W.-K., Rhee, K.-H., Kook, Y.-H.
(2003). Detection of Helicobacter pylori in Gastric Mucosa of Patients with Gastroduodenal Diseases by PCR-Restriction Analysis Using the RNA Polymerase Gene (rpoB). J. Clin. Microbiol.
41: 3387-3391
[Abstract]
[Full Text]
-
Wang, J., van Doorn, L.-J., Robinson, P. A., Ji, X., Wang, D., Wang, Y., Ge, L., Telford, J. L., Crabtree, J. E.
(2003). Regional Variation among vacA Alleles of Helicobacter pylori in China. J. Clin. Microbiol.
41: 1942-1945
[Abstract]
[Full Text]
-
Koehler, C I, Mues, M B, Dienes, H P, Kriegsmann, J, Schirmacher, P, Odenthal, M
(2003). Helicobacter pylori genotyping in gastric adenocarcinoma and MALT lymphoma by multiplex PCR analyses of paraffin wax embedded tissues. Mol. Pathol.
56: 36-42
[Abstract]
[Full Text]
-
Cao, P., Cover, T. L.
(2002). Two Different Families of hopQ Alleles in Helicobacter pylori. J. Clin. Microbiol.
40: 4504-4511
[Abstract]
[Full Text]
-
Fernando, N., Holton, J., Vaira, D., DeSilva, M., Fernando, D.
(2002). Prevalence of Helicobacter pylori in Sri Lanka as Determined by PCR. J. Clin. Microbiol.
40: 2675-2676
[Abstract]
[Full Text]
-
Andreson, H., Loivukene, K., Sillakivi, T., Maaroos, H.-I., Ustav, M., Peetsalu, A., Mikelsaar, M.
(2002). Association of cagA and vacA Genotypes of Helicobacter pylori with Gastric Diseases in Estonia. J. Clin. Microbiol.
40: 298-300
[Abstract]
[Full Text]
-
McClain, M. S., Cao, P., Iwamoto, H., Vinion-Dubiel, A. D., Szabo, G., Shao, Z., Cover, T. L.
(2001). A 12-Amino-Acid Segment, Present in Type s2 but Not Type s1 Helicobacter pylori VacA Proteins, Abolishes Cytotoxin Activity and Alters Membrane Channel Formation. J. Bacteriol.
183: 6499-6508
[Abstract]
[Full Text]
-
Vinion-Dubiel, A. D., McClain, M. S., Cao, P., Mernaugh, R. L., Cover, T. L.
(2001). Antigenic Diversity among Helicobacter pylori Vacuolating Toxins. Infect. Immun.
69: 4329-4336
[Abstract]
[Full Text]
-
Bereswill, S., Greiner, S., van Vliet, A. H. M., Waidner, B., Fassbinder, F., Schiltz, E., Kusters, J. G., Kist, M.
(2000). Regulation of Ferritin-Mediated Cytoplasmic Iron Storage by the Ferric Uptake Regulator Homolog (Fur) of Helicobacter pylori. J. Bacteriol.
182: 5948-5953
[Abstract]
[Full Text]
-
Danielsson, D, Farmery, S M, Blomberg, B, Perry, S, Rautelin, H, Crabtree, J E
(2000). Co-expression in Helicobacter pylori of cagA and non-opsonic neutrophil activation enhances the association with peptic ulcer disease. J. Clin. Pathol.
53: 318-321
[Abstract]
[Full Text]
-
Atherton, J. C., Cover, T. L., Twells, R. J., Morales, M. R., Hawkey, C. J., Blaser, M. J.
(1999). Simple and Accurate PCR-Based System for Typing Vacuolating Cytotoxin Alleles of Helicobacter pylori. J. Clin. Microbiol.
37: 2979-2982
[Abstract]
[Full Text]
-
Marais, A., Mendz, G. L., Hazell, S. L., Megraud, F.
(1999). Metabolism and Genetics of Helicobacter pylori: the Genome Era. Microbiol. Mol. Biol. Rev.
63: 642-674
[Abstract]
[Full Text]
-
Perez-Perez, G. I., Peek, R. M. Jr., Atherton, J. C., Blaser, M. J., Cover, T. L.
(1999). Detection of Anti-VacA Antibody Responses in Serum and Gastric Juice Samples Using Type s1/m1 and s2/m2 Helicobacter pylori VacA Antigens. CVI
6: 489-493
[Abstract]
[Full Text]
-
Donati, M., Storni, E., D'Apote, L., Moreno, S., Tucci, A., Poli, L., Cevenini, R.
(1999). PCR-Based Restriction Pattern Typing of the vacA Gene Provides Evidence for a Homogeneous Group among Helicobacter pylori Strains Associated with Peptic Ulcer Disease. J. Clin. Microbiol.
37: 912-915
[Abstract]
[Full Text]